Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-19-013526
Filing Date
2019-11-06
Accepted
2019-11-06 17:13:13
Documents
1
Period of Report
2019-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157307837768125.html 4  
1 FORM 4 wf-form4_157307837768125.xml 4 3915
  Complete submission text file 0001628280-19-013526.txt   5618
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MARINA PARK DRIVE SUITE 1100 BOSTON MA 02210
Business Address
TOBIN SCOTT R (Reporting) CIK: 0001199926 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 191197208